|Mr. Chuck Wagner||Pres, Treasurer & Chairman||N/A||N/A||N/A|
|Mr. George Malesek||Interim Chief Exec. Officer||N/A||N/A||N/A|
|Mr. Dimitri Theofilopolous Esq.||Legal Counsel||N/A||N/A||N/A|
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
Oncology Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.